Keeren Shah
Director of Finance/CFO bei ACTAVIA LIFE SCIENCES, INC.
Vermögen: 88 $ am 31.03.2024
Profil
Keeren Shah is currently working as a Member at The Chartered Institute of Management Accountants.
Additionally, Ms. Shah holds the position of Chief Financial Officer at OKYO Pharma Ltd., Actavia Life Sciences, Inc., AccuStem Sciences, Inc., and Tiziana Life Sciences Ltd.
In the past, Ms. Shah worked as a Finance Director at Rasna Therapeutics, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ACCUSTEM SCIENCES INC
0,00% | 31.12.2022 | 250 ( 0,00% ) | 88 $ | 31.03.2024 |
Aktive Positionen von Keeren Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Director of Finance/CFO | 31.07.2020 |
| OKYO PHARMA LIMITED | Director of Finance/CFO | 01.08.2020 |
| ACCUSTEM SCIENCES, INC. | Director of Finance/CFO | 01.08.2021 |
| TIZIANA LIFE SCIENCES LTD | Director of Finance/CFO | - |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Keeren Shah
| Unternehmen | Position | Ende |
|---|---|---|
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Private Unternehmen | 2 |
|---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Rasna Therapeutics, Inc. /Old/
Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Distribution Services |
